Ayurvedic medicine zinc Bhasma: Physicochemical evaluation, anti-diabetic activity and safety assessment

Journal of Biomedical Nanotechnology

Volumn 7, Issue 1, 2011, Pages 148-149

  Umrani, Rinku D ^a   Paknikar, Kishore M ^a  

^a AGHARKAR RESEARCH INSTITUTE   (India)

Author keywords

Acute toxicity; Cytotoxicity; Diabetic rats; HRTEM; SEM; Sub acute toxicity; Zinc Bhasma

Indexed keywords

ACUTE TOXICITY; ADVERSE EFFECT; AYURVEDIC MEDICINE; CLINICAL SIGNS; DIABETIC RATS; DOSE LEVELS; HRTEM; HUMAN USE; IN-VITRO; NANO PARTICULATES; PHYSICOCHEMICAL TECHNIQUES; SAFETY ASSESSMENTS; TOXICITY TEST;

CELL CULTURE; SCANNING ELECTRON MICROSCOPY; TOXICITY; UREA; ZINC;

CYTOTOXICITY;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AYURVEDIC DRUG; STREPTOZOCIN; UNCLASSIFIED DRUG; UREA; ZINC BHASMA; ANTIDIABETIC AGENT; METAL NANOPARTICLE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIDIABETIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AYURVEDA; BLOOD SAMPLING; CONTROLLED STUDY; CYTOTOXICITY; DRUG SAFETY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHYSICAL CHEMISTRY; RAT; REPEATED DRUG DOSE; STREPTOZOCIN DIABETES; TOXICITY TESTING; ANIMAL; CHEMICALLY INDUCED DISORDER; DIABETES MELLITUS; EXPERIMENTAL DIABETES MELLITUS; TREATMENT OUTCOME;

ANIMALS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; MEDICINE, AYURVEDIC; METAL NANOPARTICLES; RATS; STREPTOZOCIN; TREATMENT OUTCOME;

EID: 79957784125     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2011.1243     Document Type: Article

References (10)

1. A. Kumar, G. C. Nair, A. V. R. Reddy, and A. N. Garg, Bhasmas-unique ayurvedic metallic-herbal preparations, chemical characterization. Bio. Trace Ele. Res. 109, 231 (2006).
2. V. A. Dole and P. Paranjpe, A Textbook of Rasashastra, Chaukhamba Sanskrit Pratisthan, Delhi (2004).
3. T. K. Bhowmick, A. K. Suresh, S. G. Kane, A. C. Joshi, and J. R. Bellare, Physicochemical characterization of an Indian traditional medicine, Jasada Bhasma: Detection of nanoparticles containing non-stoichiometric zinc oxide. J. Nanopart. Res. 11, 655 (2009).
4. G. Oberdorster, E. Oberdorster, and J. Oberdorster, Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Env. Health Perspectives 113, 823 (2005).
5. N. Pattanaik, A. V. Singh, R. S. Pandey, B. K. Singh, M. Kumar, S. K. Dixit, and Y. B. Tripathi, Toxicology and free radicals scavenging property of tamra bhasma. Ind. J. Clin. Biochem. 18, 181 (2003).
6. S. Mitra, B. Chakraborty, P. Auddy, Tripathi, S. Sen, A. V. Saha, and B. Mukherjee, Evaluation of chemical constituents and free-radical scavenging activity of Swarna bhasma (gold ash), an ayurvedic drug. J Ethnopharmacol. 80, 147 (2002).
7. V. Sharma, R. K. Shukla, N. Saxena, D. Parmar, M. Das, and A. Dhawan, DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Toxicol. Lett. 185, 211 (2009).
8. OECD Guideline 420 for the testing of chemicals, Acute Oral Toxicity - Fixed Dose Procedure, adopted 17th December (2001).
9. OECD Guideline 407 for the testing of chemicals, Repeated Dose 28-day Oral Toxicity in Rodents, adopted 27th July (1995).
10. A. Dhawan and V. Sharma, Toxicity assessment of nanomaterials: Methods and challenges. Anal. Bioanal. Chem. 398, 589 (2010).